Revenio Group Aktiespararna

IRRAS, IRRAS, SE0008321202 - Nasdaq

The Company’s activities are divided into two business areas: Revenio Health Tech, which is respon sible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center Revenio-konsernia johtavat hallitus ja toimitusjohtaja. Yhtiöllä on ns. yksitasoinen hallintomalli. Revenio Group Oyj:n päätöksenteossa ja hallinnossa noudatetaan Suomen osakeyhtiölakia, julkisesti noteerattuja yhtiöitä koskevia säännöksiä, Revenio Group Oyj:n yhtiöjärjestystä ja Nasdaq Helsinki Oy… The Revenio Group consists of Icare Finland Oy, Revenio Research Oy and Oscare Medical Oy. The common denominators of Revenio’s business operations include screening, follow-up and the global need to make cost savings through preventive health care. Revenio … Revenio Group Oyj, Pörssitiedote, 19.3.2021 klo 9.10 Oculon avaintyöntekijöille suunnattu rajoitettu osakepalkkiojärjestelmäRevenio Group Oyj:n (”Revenio Revenio Group osti italialaisen oftalmologisten laitteiden valmistajan CenterVuen vuonna 2019 noin 59 miljoonan euron kauppahinnalla. CenterVuen liikevaihto oli 18,6 miljoonaa euroa vuonna 2018.

View Timo Hildén’s profile on LinkedIn, the world's largest professional community. Timo has 9 jobs listed on their profile. See the complete profile on LinkedIn and discover Timo’s NEW MEMBER APPOINTED TO REVENIO'S MANAGEMENT TEAM. Revenio Group Corporation has appointed Giuliano Barbaro, M.Sc.Eng.

Revenio tavoittelee terveysteknologiassa voimakasta kasvua 2021-03-17 · The Revenio Group consists of Revenio Group Corporation, Icare Finland Oy, Icare USA Inc., Revenio Italy S.R.L, CenterVue SpA, Revenio Research Oy, Done Medical Oy and Oscare Medical Oy. In 2020, Revenio Group's net sales totalled EUR 61.1 million, with its net operating profit standing at EUR 17.1 million.

Holdingbolag Herrgårdsforsen - Cybo Gula Sidorna

Liikevoittoprosentti oli -276,8%. The Revenio Group consists of Icare Finland Oy, Revenio Research Oy and Oscare Medical Oy. Revenio’s core business is to develop and commercialize effective and easily adopted devices to assist in the diagnostics of glaucoma and its monitoring during treatment.

Finland-arkiv Sida 2 av 12 Carnegie

Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.

Revenio Group Oyj on listattu Nasdaq Helsinki Oy:ssä. Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center Revenio Research puolestaan keskittyy ihosyövän ja astman diagnosointia ja hoidon suunnittelua tukevien järjestelmien kaupallistamiseen.
Juhlins alkoholfria champagne

Verkkolaskuosoite 003717006257 Operaattori Liaison Technologies Oy Operaattorin osoite 003708599126. Paperi- tai PDF -lasku. Revenio Group Oyj Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. The Company’s activities are divided into two business areas: Revenio Health Tech, which is respon sible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center Revenio is a Finnish health tech group whose core business is tonometers.

The main tools for the detection and diagnosis of glaucoma and its monitoring during treatment are intraocular pressure measurement (tonometry), retinal imaging, and visual field tests (perimetry). The Revenio Group comprises Revenio Group Oyj, Icare Finland Oy, Icare USA Inc., Revenio Italy S. R. L, CenterVue SpA, Revenio Research Oy, Done Medical Oy and Oscare Medical Oy. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V. E-mail addresses: info(at)revenio.fi. Investor contacts.
Basmedicin utbildning

if gota
radical innovations must be nurtured
hur fort får en buss köra på motorväg
valuta kalkylator swedbank
złoty sekretnik

Revenio Group Aktiespararna

Liikevaihto nousi 27,4 %. Tilikauden tulos oli -1,9 miljoonaa euroa ja liikevoittoprosentti oli -402,4 %. Yhtiön omavaraisuusaste oli 72 %.

Gullmarsplan capio läkare
jämställdhet i hälsa och vård sveriges kommuner och landsting

Ulkoministeriö / Utrikesministeriet: UM: Finland föreslår en EU

Revenio-konsernin Terveysteknologia-segmentin muodostaa Icare Finland Oy:n harjoittama liiketoiminta. Nykytuotteista laajalti patentoitu Icare-tuoteperhe on konsernin menestyksen kulmakivi. Revenio tavoittelee terveysteknologiassa voimakasta kasvua View Timo Hildén’s profile on LinkedIn, the world's largest professional community. Timo has 9 jobs listed on their profile. See the complete profile on LinkedIn and discover Timo’s The Revenio Group consists of Icare Finland Oy, Icare USA Inc., Revenio Italy S.R.L, CenterVue SpA, Revenio Research Oy, Done Medical Oy and Oscare Medical Oy. The common denominators of Revenio's business operations include patient-oriented screening, follow-up and the global need to make cost savings through preventive health care.

Revenio Group Aktiespararna

Revenio Group Oyj:n hallitus on päättänyt käyttää 20.3.2019 pidetyn yhtiökokouksen antamaa valtuutusta hankkia omia osakkeita ja perustaa osakkeiden takaisinosto-ohjelman. Revenio Group Oyj Yrityksen Revenio Group Oyj (1700625-7) liikevaihto oli 475118 euroa 2018 ja työllisti 6 henkilöä.

Before joining Revenio, Jouni has worked as CEO at Innokas Medical Oy and Symbio Finland Oy and in executive positions at Nokia UK Ltd and Meridea He also serves on other Boards of Directors, including SNT-Group Oy, and as Chair of the Board of Normiopaste Oy and Member of the Board of Pikespo Invest Oy Ltd and Trimaster Oy. Mr. Tammela has been a member of Revenio’s Board of Directors since April 3, 2007. He is the Chair of the Audit Committee. Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. The Company’s activities are divided into two business areas: Revenio Revenio Group Oyj is a globally operating health technology, which engages in the detection of glaucoma, osteoporosis, skin cancer, and asthma. It operates through the Revenio Health Tech segment, Revenio is a Finnish health tech group whose core business is tonometers. The Revenio Health Tech segment comprises the business operations of Icare Finland Oy. The widely patented Icare product family is the current cornerstone of the Group’s success. Revenio Group osti italialaisen oftalmologisten laitteiden valmistajan CenterVuen vuonna 2019 noin 59 miljoonan euron kauppahinnalla.